November 13, 2007in Patents, Pharmaceutical Drugs1by Editor174 An Innovative Policy in the Law of Innovation: So Why the Outcry? In January 2006, the Patent Office of Chennai rejected the patent application by Novartis for patent of the drug Gleevec (chemically known as imatinib mesylate). Since then till date, the…
